Effects of warm climatic periods on dairy cow behaviour and production in Scotland

Global warming is resulting in an overall increase in temperatures and in the frequency of extreme weather events. In dairy cattle, thresholds within the temperature-humidity index (THI) have been used to indicate points at which cattle will likely experience thermal stress (e.g., a THI threshold of 75 predicts thermal stress). However, high-yielding dairy cows that reside in temperate maritime climates may experience some degree of thermal discomfort below this threshold particularly when they are housed. Housing often results in high levels of humidity. The use of technology such as activity monitors and automated intake measures allow us to monitor responses. The aim of this study was to use technological solutions to assess behavioural changes in response to moderate increases in THI levels. Data from dairy cattle on an experimental unit were used. Data on daily lying times, lying bout frequency, step count, feed and water intake and milk yield were extracted for 8 pairs of warmer (THI<65) and 8 matching cooler (THI=43 to 60) periods. Warm and cool periods were no more than 5 weeks apart to ensure that the data from the same animals were being compared. The first three days from each period were analysed. Results showed that total daily lying time was shorter during warmer periods than cooler periods (P<0.05; means and SEMs (h): warm: 11.3±0.06h; cool: 11.8±0.06h). However, there was no effect of THI level on the no. of steps taken by cows (P>0.05 (counts) warm: 868±8 steps; cool: 878±9 steps). Water intake was higher during warm periods (P<0.05: (l) = warm: 81.2±0.7l; cool: 72.1±0.6), but there was no difference in feed intake (warm: 57.6±0.5kg; cool: 57.1±0.3kg). Milk yield was lower during warm periods than cool periods (P<0.05; (l): warm: 31.8±0.3; cool: 32.7±0.2). This suggests that behaviour and milk yield are mildly adversely affected even in conditions that are not traditionally regarded as exceeding cows’ ability to cope with thermal challenge

Effects of warm climatic periods on dairy cow behaviour and production in Scotland

Global warming is resulting in an overall increase in temperatures and in the frequency of extreme weather events. In dairy cattle, thresholds within the temperature-humidity index (THI) have been used to indicate points at which cattle will likely experience thermal stress (e.g., a THI threshold of 75 predicts thermal stress). However, high-yielding dairy cows that reside in temperate maritime climates may experience some degree of thermal discomfort below this threshold particularly when they are housed. Housing often results in high levels of humidity. The use of technology such as activity monitors and automated intake measures allow us to monitor responses. The aim of this study was to use technological solutions to assess behavioural changes in response to moderate increases in THI levels. Data from dairy cattle on an experimental unit were used. Data on daily lying times, lying bout frequency, step count, feed and water intake and milk yield were extracted for 8 pairs of warmer (THI<65) and 8 matching cooler (THI=43 to 60) periods. Warm and cool periods were no more than 5 weeks apart to ensure that the data from the same animals were being compared. The first three days from each period were analysed. Results showed that total daily lying time was shorter during warmer periods than cooler periods (P<0.05; means and SEMs (h): warm: 11.3±0.06h; cool: 11.8±0.06h). However, there was no effect of THI level on the no. of steps taken by cows (P>0.05 (counts) warm: 868±8 steps; cool: 878±9 steps). Water intake was higher during warm periods (P<0.05: (l) = warm: 81.2±0.7l; cool: 72.1±0.6), but there was no difference in feed intake (warm: 57.6±0.5kg; cool: 57.1±0.3kg). Milk yield was lower during warm periods than cool periods (P<0.05; (l): warm: 31.8±0.3; cool: 32.7±0.2). This suggests that behaviour and milk yield are mildly adversely affected even in conditions that are not traditionally regarded as exceeding cows’ ability to cope with thermal challenge

SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)

Small-cell lung cancer (SCLC) accounts for 15% of lung cancers. Only one-third of patients are diagnosed at limited stage. The median survival remains to be around 15-20 months without significative changes in the strategies of treatment for many years. In stage I and IIA, the standard treatment is the surgery followed by adjuvant therapy with platinum-etoposide. In stage IIB-IIIC, the recommended treatment is early concurrent chemotherapy with platinum-etoposide plus thoracic radiotherapy followed by prophylactic cranial irradiation in patients without progression. However, in the extensive stage, significant advances have been observed adding immunotherapy to platinum-etoposide chemotherapy to obtain a significant increase in overall survival, constituting the new recommended standard of care. In the second-line treatment, topotecan remains as the standard treatment. Reinduction with platinum-etoposide is the recommended regimen in patients with sensitive relapse (≥ 3 months) and new drugs such as lurbinectedin and immunotherapy are new treatment options. New biomarkers and new clinical trials designed according to the new classification of SCLC subtypes defined by distinct gene expression profiles are necessary

Divergence of Arctic shrub growth associated with sea ice decline

Arctic sea ice extent (SIE) is declining at an accelerating rate with a wide range of ecological consequences. However, determining sea ice effects on tundra vegetation remains a challenge. In this study, we examined the universality or lack thereof in tundra shrub growth responses to changes in SIE and summer climate across the Pan-Arctic, taking advantage of 23 tundra shrub-ring chronologies from 19 widely distributed sites (56°N to 83°N). We show a clear divergence in shrub growth responses to SIE that began in the mid-1990s, with 39% of the chronologies showing declines and 57% showing increases in radial growth (decreasers and increasers, respectively). Structural equation models revealed that declining SIE was associated with rising air temperature and precipitation for increasers and with increasingly dry conditions for decreasers. Decreasers tended to be from areas of the Arctic with lower summer precipitation and their growth decline was related to decreases in the standardized precipitation evapotranspiration index. Our findings suggest that moisture limitation, associated with declining SIE, might inhibit the positive effects of warming on shrub growth over a considerable part of the terrestrial Arctic, thereby complicating predictions of vegetation change and future tundra productivity

Growth rings show limited evidence for ungulates' potential to suppress shrubs across the Arctic

Global warming has pronounced effects on tundra vegetation, and rising mean temperatures increase plant growth potential across the Arctic biome. Herbivores may counteract the warming impacts by reducing plant growth, but the strength of this effect may depend on prevailing regional climatic conditions. To study how ungulates interact with temperature to influence growth of tundra shrubs across the Arctic tundra biome, we assembled dendroecological data from 20 sites, comprising 1153 individual shrubs and 223 63 annual growth rings. Evidence for ungulates suppressing shrub radial growth was only observed at intermediate summer temperatures (6.5 degrees C-9 degrees C), and even at these temperatures the effect was not strong. Multiple factors, including forage preferences and landscape use by the ungulates, and favourable climatic conditions enabling effective compensatory growth of shrubs, may weaken the effects of ungulates on shrubs, possibly explaining the weakness of observed ungulate effects. Earlier local studies have shown that ungulates may counteract the impacts of warming on tundra shrub growth, but we demonstrate that ungulates' potential to suppress shrub radial growth is not always evident, and may be limited to certain climatic conditions

Growth rings show limited evidence for ungulates’ potential to suppress shrubs across the Arctic

Global warming has pronounced effects on tundra vegetation, and rising mean temperatures increase plant growth potential across the Arctic biome. Herbivores may counteract the warming impacts by reducing plant growth, but the strength of this effect may depend on prevailing regional climatic conditions. To study how ungulates interact with temperature to influence growth of tundra shrubs across the Arctic tundra biome, we assembled dendroecological data from 20 sites, comprising 1153 individual shrubs and 223 63 annual growth rings. Evidence for ungulates suppressing shrub radial growth was only observed at intermediate summer temperatures (6.5 ◦C–9 ◦C), and even at these temperatures the effect was not strong. Multiple factors, including forage preferences and landscape use by the ungulates, and favourable climatic conditions enabling effective compensatory growth of shrubs, may weaken the effects of ungulates on shrubs, possibly explaining the weakness of observed ungulate effects. Earlier local studies have shown that ungulates may counteract the impacts of warming on tundra shrub growth, but we demonstrate that ungulates’ potential to suppress shrub radial growth is not always evident, and may be limited to certain climatic conditions.Research Council of Norwayhttp://iopscience.iop.org/1748-9326dm2022Mammal Research InstituteZoology and Entomolog

SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).

Small-cell lung cancer (SCLC) accounts for 15% of lung cancers. Only one-third of patients are diagnosed at limited stage. The median survival remains to be around 15-20 months without significative changes in the strategies of treatment for many years. In stage I and IIA, the standard treatment is the surgery followed by adjuvant therapy with platinum-etoposide. In stage IIB-IIIC, the recommended treatment is early concurrent chemotherapy with platinum-etoposide plus thoracic radiotherapy followed by prophylactic cranial irradiation in patients without progression. However, in the extensive stage, significant advances have been observed adding immunotherapy to platinum-etoposide chemotherapy to obtain a significant increase in overall survival, constituting the new recommended standard of care. In the second-line treatment, topotecan remains as the standard treatment. Reinduction with platinum-etoposide is the recommended regimen in patients with sensitive relapse (≥ 3 months) and new drugs such as lurbinectedin and immunotherapy are new treatment options. New biomarkers and new clinical trials designed according to the new classification of SCLC subtypes defined by distinct gene expression profiles are necessary

Addition of immune checkpoint inhibitors to chemotherapy vs chemotherapy alone as first-line treatment in extensive-stage small-cell lung carcinoma: a systematic review and meta-analysis

Introduction: The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment improves survival in extensive-stage small-cell lung cancer (ES-SCLC). The aim of this meta-analysis was to determine the relative efficacy of first-line ICIs compared with CT in patients with ES-SCLC. Methods: Two independent reviewers extracted relevant data according to PRISMA guidelines and assessed the risk of bias using the Cochrane Collaboration's risk-of-bias tool. Meta-analysis was conducted using random-effects models to calculate an average effect size for overall survival (OS), progression-free survival (PFS), and safety outcomes in the overall populations and clinically relevant subgroups. Results: A literature search of PubMed and Embase was performed. Six randomized controlled clinical trials (IMpower133, CHECKMATE-451, CASPIAN, KEYNOTE-604, and phase II and III ipilimumab plus CT trials) with a total of 3757 patients were included. Compared with CT alone, ICIs plus CT showed a favourable effect on OS (hazard ratio [HR] 0.85; 95% confidence intervals [CI] 0.79-0.96) and PFS (HR 0.78; 95% CI 0.72-0.83) but a non-significant increase in the risk of experiencing any adverse event (relative risk, 1.05; 95% CI 0.99-1.11). The estimated HR for OS favoured ICI combinations in all planned subgroups according to age (< 65 years/≥ 65 years), sex (men/women), and ECOG performance status (0/1). Analysis by specific ICI revealed significant improvements in OS only for atezolizumab + CT (HR 1.36; 95% CI 1.09-1.69) and durvalumab + CT (HR 1.35; 95% CI 1.12-1.62) compared with CT alone. Conclusion: Combining anti-programmed cell death ligand 1 antibodies with platinum/etoposide is a superior therapeutic approach compared to CT alone for the first-line treatment of patients with ES-SCLC